In this review, we discuss the interaction between cancer and markers of inflammation (such
as levels of inflammatory cells and proteins) in the circulation, and the potential benefits of …

Inflammatory proteins activate platelets, which have been observed to be directly related to
cancer progression and development. The aim of this systematic review is to investigate the …

Abstract Background and Aims: Published data on the prognostic role of neutrophil-to-
lymphocyte ratio (NLR) in ovarian cancer are controversial. We conducted this meta …

Background Platelet-to-lymphocyte (PLR) and Neutrophil-to-Lymphocyte (NLR) ratios have
been extensively investigated in cancer. However, to date, actual guidelines concerning …

Circulating leukocytes are an important part of the immune system. The aim of this work is to
explore the role of preoperative circulating leukocytes in serous ovarian carcinoma and …

The purpose of this study was to investigate whether the neutrophil–lymphocyte ratio (NLR)
and platelet–lymphocyte ratio (PLR) can be used as supplementary tools to differentiate …

Objective To assess the utility of hematologic, inflammatory, and immunologic biomarkers for
differentiating between ovarian cancer and endometriosis. Methods Data were …

Background Neoadjuvant chemotherapy (NACT) followed by interval debulking surgery
(IDS) is the recommended approach in patients with advanced epithelial ovarian cancer …

Background: Given the role of inflammation in carcinogenesis, this study investigated the
utility of pre-treatment inflammatory markers as associative indicators for advanced-stage …

Objective: To evaluate the role of inflammatory markers for distinguishing malignant and
benign ovarian masses. Methods: Preoperative demographic, clinicopathologic, and …